Healthcare engagement in the Asia-Pacific (APAC) region is increasingly shifting from traditional settings to digital platforms, patient forums, and social media feeds.
Despite APAC accounting for over half of global social media users, its pharmaceutical sector still lags in generating structured real-world evidence (RWE), developing patient-centric strategies, and implementing digital listening.
The white paper “Harnessing the Digital Voice: High-Impact Social Listening for Pharma in the Diverse APAC Landscape” highlights the untapped potential of social listening in the region’s pharmaceutical sector.
Authored by Ankit Kulshrestha, Abheek Bose, and Tanay Sharma, the report underscores the importance of integrating social listening into pharma strategies to bridge the gap between digital health conversations and real-world evidence generation. Effective social listening can transform digital dialogues into strategic tools for Medical Affairs, Market Access, and Marketing teams, enabling real-time, patient-aligned decision-making.
Download the full article to discover how EVERSANA can help turn social chatter into actionable insights, aiding pharma companies in navigating the region’s digital complexity effectively.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…